Pharmaceutical
Indications

 

50 Results were found on Technologies

Leading Researchers:
10-2021-1659

Novel BCR-ABL1 Inhibitors for Treating Imatinib Resistance Cancer

Read More >

Leading Researchers:
2-2021-1672

High-Efficiency Therapeutic Genome Editing for Cancer Therapy

Read More >

Leading Researchers:
10-2020-1476

Unique Cocktail of Neutralizing Antibodies against SARS-CoV-2

We have identified eight potent neutralizing antibodies (mAbs) from recovered COVID-19 patients for COVID-19 treatment. These antibodies may be used as pre-exposure prophylaxis, i.e., as short-term protection from infection for populations at risk... Read More >

Leading Researchers:
10-2020-1438

Plant-Derived Anti- Herpesvirus Composition

Herpes simplex virus infection is commonly known as herpes. The two types of herpes simplex virus are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic... Read More >

Leading Researchers:
5-2020-1362

An early stage screening tool for distinguishing pregnant women having an increased risk of developing preeclampsia

Preeclampsia is one of the most dangerous pregnancy complications occurs in the second or third trimester, affecting 3–8% of pregnancies; it is the leading cause of maternal and perinatal mortality and morbidity. Preeclampsia cannot reliably be... Read More >

Leading Researchers:
2-2020-1431

A new checkpoint inhibitor – variant of PDL1

Read More >

2-2020-1408

Development of an effective dietary supplement to prevent and treat coronavirus and other viral infections

While most groups are working on the development of drugs and vaccines for SARS-CoV-2, we aim at finding a short-term solution to be ready for use ASAP. Here, we propose a healthy dietary supplement (a combination of several dietary supplements)... Read More >

Leading Researchers:
2-2020-1376

New Chemiluminescent Protease Probe for Rapid, Sensitive, and Inexpensive Detection of Live Mycobacterium tuberculosis

Tuberculosis (TB) is a top-ten cause of death worldwide. Successful treatment is often limited by insufficient diagnostic capabilities, especially at the point of care in low-resource settings. The ideal diagnostic must be fast, be cheap, and... Read More >

Leading Researchers:
10-2019-1337

Anti-Cancer Nanotherapy: Targeted Potent Conjugated BRAF/MEK Inhibitors

In the last decade, deep understanding of key oncogenes and signaling pathways, involved in cancer pathogenesis and progression were achieved, leading to new treatment options. However, the number of patients with metastatic melanoma continue... Read More >

Leading Researchers:
10-2019-1238

Pharmacological uses of combinations of CBD with other molecules to improve bone healing/regeneration

Read More >